GENE ONLINE|News &
Opinion
Blog

Tulip Chakraborty

WRITTEN BY Tulip Chakraborty

Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
Canadian Biotech Launches Screening Panel for Detecting Multiple Cancers from Single Blood Sample
2021-04-07
CAR-M Therapy – Trojan Horse for Solid Cancer Treatment?
2021-04-05
FTC Blocks Illumina’s $7 Billion Acquisition Bid to Restrict Monopoly of Cancer Diagnostic Market
2021-04-01
Merck Spinoff Expands Healthcare Business by Investing $240 Million in Acquiring Alydia Health
2021-03-31
Novel COVID-19 “Double Mutant” Poses New Challenge to India’s Vaccine Rollout
2021-03-25
Novartis’ Acquired Asset from Endocyte Shines in Phase 3 Prostate Cancer Trial
2021-03-24
AstraZeneca’s COVID-19 Vaccine Shows 79% Efficacy in US Trial, Eyes FDA Approval
2021-03-22
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
2021-03-20
North Carolina-Based Gene Therapy Startup Bags $81.5 Million in Series B Funding
2021-03-17
AVEO Oncology Rejoices FDA Approval for TKI, Finds Able Partner in BMS to Trial Combo Therapy for Kidney Cancer
2021-03-13
Eli Lilly’s Antibody Cocktail Shines in Phase 3 Study, Significantly Reduces COVID-19 Deaths
2021-03-11
AnaptysBio’s Dermatology Drug Hits Roadblock in Phase 2 Trial
2021-03-09
Tempest Lands Big Pharma Partnership to Trial Combo Therapy Against “Hard-To-Treat” Liver Cancer
2021-03-05
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03
1 2 3 … 8
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top